Efficacy of the Therapy With BRAINMAX® Using fMRI for the Treatment of Patients With Asthenia After COVID-19

Clinical trial NCT05939622 · COMPLETED

Trial details

NCT number: NCT05939622
Sponsor: Promomed, LLC
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Asthenia COVID-19 Functional MRI Cognitive Impairment

Start date: 2022-05-18
Primary completion: 2022-12-20
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.